ATRX and neuroblastoma: Consequently, the DNA-replicative stress caused by ATRX mutations and MYCN amplification causes synthetic lethality in neuroblastoma, representing an uncommon instance in which the inactivation of a tumor-suppressor gene and activation of an oncogene are incompatible.